logo

LRMR

LarimarยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

LRMR Profile

Larimar Therapeutics, Inc.

A clinical-stage biotechnology company that developing treatments for complex rare diseases

Pharmaceutical
11/22/2005
06/19/2014
NASDAQ Stock Exchange
65
12-31
Common stock
Three Bala Plaza East, Suite 506, Bala Cynwyd, Pennsylvania 19004
--
Larimar Therapeutics, Inc., was incorporated under the laws of the State of Delaware on November 22, 2005. The Company is a clinical-stage biotechnology company focused on developing treatments for patients with complex rare diseases using the Company's novel Cell-Penetrating Peptide (" CPP ") technology platform.